Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 9/20 | 0.52 |
| ▸ | CA2 | P00918 | 9/20 | 0.52 |
| ▸ | CA9 | Q16790 | 7/20 | 0.52 |
| ▸ | CA12 | O43570 | 6/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.52 |
| ▸ | CA7 | P43166 | 4/20 | 0.52 |
| ▸ | CA3 | P07451 | 3/20 | 0.52 |
| ▸ | CA4 | P22748 | 3/20 | 0.52 |
| ▸ | CA6 | P23280 | 3/20 | 0.52 |
| ▸ | CA5A | P35218 | 3/20 | 0.52 |
| ▸ | CA13 | Q8N1Q1 | 3/20 | 0.52 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.52 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.47 |
| ▸ | F2 | P00734 | 2/20 | 0.44 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.44 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.44 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.44 |
| ▸ | IDO1 | P14902 | 2/20 | 0.43 |
| ▸ | MMP1 | P03956 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30865768 | 0.89 | CA1 (0.53) | CA1CA2CA9CA12CA14 | |
| SCHEMBL19127566 | 0.86 | CA1 (0.47) | CA1CA2CA9CA12CA14 | |
| SCHEMBL10615596 | 0.84 | CA1 (0.48) | CA1CA2CA9CA12CA14 | |
| SCHEMBL10615554 | 0.84 | CA1 (0.48) | CA1CA2CA9CA12CA14 | |
| SCHEMBL1759087 | 0.84 | CA1 (0.48) | CA1CA2CA9CA12CA14 | |
| SCHEMBL27961960 | 0.83 | CA1 (0.44) | CA1CA2CA9CA12CA14 | |
| SCHEMBL13725706 | 0.83 | CA1 (0.47) | CA1CA2CA9CA12CA14 | |
| SCHEMBL1759088 | 0.83 | TSHR (0.49) | CA1CA2CA9CA12CA14 | |
| SCHEMBL1759109 | 0.83 | CA2 (0.47) | CA1CA2CA9CA12CA14 | |
| SCHEMBL27935675 | 0.83 | CA1 (0.47) | CA1CA2CA9CA12CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8835685-B2 | Process for the preparation of contrast agents | BRACCO IMAGING S.P.A. (IT) | 2014-09-16 | — | — | US | disclosed |
| EP-2593423-B1 | PROCESS FOR THE PREPARATION OF CONTRAST AGENTS | BRACCO IMAGING SPA (IT) | 2014-09-03 | — | — | EP | disclosed |
| US-20130131382-A1 | Process For The Preparation Of Contrast Agents | BRACCO IMAGING S.P.A. (IT) | 2013-05-23 | — | — | US | disclosed |
| EP-2593423-A1 | PROCESS FOR THE PREPARATION OF CONTRAST AGENTS | Bracco Imaging S.p.A (IT) | 2013-05-22 | — | — | EP | disclosed |
| WO-2012007547-A1 | PROCESS FOR THE PREPARATION OF CONTRAST AGENTS | BRACCO IMAGING S.P.A. (IT) | 2012-01-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130131382-A1 | Process For The Preparation Of Contrast Agents | SLC1A5, SLC30A5, SLC9B2 | CA1 1567/4885CA2 1445/4885CA9 350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.